Keeler T Homas Management LLC Repligen Corp Transaction History

Keeler T Homas Management LLC

  • $234 Million
  • Q3 2025

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025
SELL
$127.24 - $174.24 $521,684 - $714,384
-4,100 Reduced 45.66%
4,879 $620,000
Q4 2024

Feb 04, 2025
BUY
$123.41 - $160.92 $451,927 - $589,289
3,662 Added 68.87%
8,979 $1.29 Million
Q3 2024

Oct 17, 2024
BUY
$119.79 - $167.35 $636,923 - $889,799
5,317 New
5,317 $791,000
Q3 2023

Oct 26, 2023
BUY
$138.78 - $176.51 $373,318 - $474,811
2,690 New
2,690 $427,000

Others Institutions Holding RGEN

# of Institutions
525
Shares Held
59.3M
Call Options Held
321K
Put Options Held
667K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $8.46B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Keeler T Homas Management LLC Portfolio

Follow Keeler T Homas Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keeler T Homas Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keeler T Homas Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email